API, one of Australia’s largest pharmacy wholesalers, to stock Bod’s entire natural medicines range – including new products, SediStress and Enterofytol
Products have now been classed as part of API’s ‘core range’ which allows for better market positioning, improved working capital management and centralised deliveries
Company has also launched new pack sizes for brands to secure additional ‘on shelf’ presence
Company to work with API to promote products through its network of ~2,000 pharmacies including Priceline, Chemsave and Pharmacy 4 Less – allowing accelerated penetration and broader distribution footprint
All brands to be live in API’s system by mid-April – sales expected shortly thereafter. SediStress to follow in July
Discussions progressing well with other leading wholesalers to drive growth – additional agreements expected near term
Well done BDA - another solid development!
BDA Price at posting:
36.5¢ Sentiment: Buy Disclosure: Held
